-
Lumateperone, sold
under the
brand name Caplyta, is an
atypical antipsychotic medication of the
butyrophenone class. It is
approved for the
treatment of...
-
commonly used
antipsychotic (200
times more
potent than chlorpromazine)
Lumateperone, an
atypical antipsychotic used for
schizophrenia and
bipolar depression...
-
Levosulpiride –
approved in low
doses for
major depressive disorder Lumateperone (Caplyta) –
approved as a
monotherapy for
bipolar depression Lurasidone...
- Levomepromazine, Lisdexamfetamine, Lithium, Lorazepam, Lorediplon, Loxapine,
Lumateperone,
Lurasidone Maprotiline, Melperone, Meprobamate, Mesoridazine, Methamphetamine...
-
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063
Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724
Adrafinil Aplindore...
- the FDA in the
United States. Cariprazine, Quetiapine, lurasidone, and
lumateperone have been approved, as monotherapies, for
bipolar depression, but as...
- of first-generation (typical) antipsychotics.
Lumateperone (Caplyta) – In
December 2019,
lumateperone, a
presynaptic D2
receptor partial agonist and...
-
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063
Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724
Adrafinil Aplindore...
-
opioid withdrawal and
opioid use disorder. IHCH-7086 IHCH-7079 IHCH-7113
Lumateperone "ITI 333". AdisInsight. 16
April 2024.
Retrieved 23
October 2024. Li...
-
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063
Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724
Adrafinil Aplindore...
